ITRM930034A0 - Agente attivo per ridurre il livello ematico di glucocorticoidi e prevenire disturbi cerebrali da stress e senilita'. - Google Patents

Agente attivo per ridurre il livello ematico di glucocorticoidi e prevenire disturbi cerebrali da stress e senilita'.

Info

Publication number
ITRM930034A0
ITRM930034A0 ITRM930034A ITRM930034A ITRM930034A0 IT RM930034 A0 ITRM930034 A0 IT RM930034A0 IT RM930034 A ITRM930034 A IT RM930034A IT RM930034 A ITRM930034 A IT RM930034A IT RM930034 A0 ITRM930034 A0 IT RM930034A0
Authority
IT
Italy
Prior art keywords
senility
glucocorticoids
stress
reduce
active agent
Prior art date
Application number
ITRM930034A
Other languages
English (en)
Inventor
Vincenzo Politi
Mario Materazzi
Stazio Giovanni Di
Luca Giovanna De
Original Assignee
Polifarma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Polifarma Spa filed Critical Polifarma Spa
Priority to ITRM930034A priority Critical patent/IT1261165B/it
Publication of ITRM930034A0 publication Critical patent/ITRM930034A0/it
Priority to AT93830530T priority patent/ATE142878T1/de
Priority to ES93830530T priority patent/ES2093953T3/es
Priority to EP93830530A priority patent/EP0608671B1/en
Priority to DE69304885T priority patent/DE69304885T2/de
Priority to US08/179,203 priority patent/US5447951A/en
Priority to JP6005893A priority patent/JP2562278B2/ja
Publication of ITRM930034A1 publication Critical patent/ITRM930034A1/it
Application granted granted Critical
Publication of IT1261165B publication Critical patent/IT1261165B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ITRM930034A 1993-01-25 1993-01-25 Agente attivo per ridurre il livello ematico di glucocorticoidi e prevenire disturbi cerebrali da stress e senilita'. IT1261165B (it)

Priority Applications (7)

Application Number Priority Date Filing Date Title
ITRM930034A IT1261165B (it) 1993-01-25 1993-01-25 Agente attivo per ridurre il livello ematico di glucocorticoidi e prevenire disturbi cerebrali da stress e senilita'.
AT93830530T ATE142878T1 (de) 1993-01-25 1993-12-29 Verwendung der 3-indolbrenztraubensäure zur erniedrigung der glucocorticoidblutspiegel und zur vorbeugung cerebraler störungen
ES93830530T ES2093953T3 (es) 1993-01-25 1993-12-29 Empleo del acido 3-indolpiruvico para reducir el nivel de glucocorticoides en sangre y para prevenir transtornos cerebrales.
EP93830530A EP0608671B1 (en) 1993-01-25 1993-12-29 Use of 3-indolepyruvic acid to reduce the level of glucocorticoids in the blood and to prevent cerebral disturbances
DE69304885T DE69304885T2 (de) 1993-01-25 1993-12-29 Verwendung der 3-Indolbrenztraubensäure zur Erniedrigung der Glucocorticoidblutspiegel und zur Vorbeugung cerebraler Störungen
US08/179,203 US5447951A (en) 1993-01-25 1994-01-10 Method for reducing the level of glucocorticoids in the blood and preventing cerebral disturbances
JP6005893A JP2562278B2 (ja) 1993-01-25 1994-01-24 血液中グルココルチコイドレベルの降下剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM930034A IT1261165B (it) 1993-01-25 1993-01-25 Agente attivo per ridurre il livello ematico di glucocorticoidi e prevenire disturbi cerebrali da stress e senilita'.

Publications (3)

Publication Number Publication Date
ITRM930034A0 true ITRM930034A0 (it) 1993-01-25
ITRM930034A1 ITRM930034A1 (it) 1994-07-25
IT1261165B IT1261165B (it) 1996-05-09

Family

ID=11401415

Family Applications (1)

Application Number Title Priority Date Filing Date
ITRM930034A IT1261165B (it) 1993-01-25 1993-01-25 Agente attivo per ridurre il livello ematico di glucocorticoidi e prevenire disturbi cerebrali da stress e senilita'.

Country Status (7)

Country Link
US (1) US5447951A (it)
EP (1) EP0608671B1 (it)
JP (1) JP2562278B2 (it)
AT (1) ATE142878T1 (it)
DE (1) DE69304885T2 (it)
ES (1) ES2093953T3 (it)
IT (1) IT1261165B (it)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2440605C (en) * 2001-03-23 2012-01-10 Corcept Therapeutics, Inc. Methods for treating stress disorders using glucocorticoid receptor-specific antagonists
US7371763B2 (en) * 2001-04-20 2008-05-13 Bayer Pharmaceuticals Corporation Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
CN103860694A (zh) * 2014-02-14 2014-06-18 四川蜀源博业医药科技有限公司 一种鼻腔用离子敏感型原位凝胶剂及其制备方法和用途
JP7093961B2 (ja) * 2018-02-13 2022-07-01 国立大学法人金沢大学 ストレス低減薬剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1148618B (it) * 1982-10-11 1986-12-03 Polifarma Spa Procedimento enzimatico per la produzione di acido 3-indolpiruvico e utilizzazione farmaceutica di questo
IT1184282B (it) * 1985-06-28 1987-10-22 Polifarma Spa Procedimento per la produzione di alfa-chetoacidi indolici a partire da un rispettivo alfa-ammino-acido,particolarmente per produrre acido indolpiruvico
IT1206078B (it) * 1987-06-03 1989-04-14 Polifarma Spa Procedimento per la produzione di acido 3-indolpiruvico e suoi derivati loro uso farmaceutico
IT1224546B (it) * 1988-09-29 1990-10-04 Polifarma Spa Utilizzatore farmaceutica di acido 3 -indolpiruvico come agente inibitore di patologie degenerative
IT1232167B (it) * 1989-08-08 1992-01-25 Polifarma Spa Uso cosmetico di acido 3-indolpiruvico

Also Published As

Publication number Publication date
ITRM930034A1 (it) 1994-07-25
JPH06234634A (ja) 1994-08-23
JP2562278B2 (ja) 1996-12-11
ES2093953T3 (es) 1997-01-01
ATE142878T1 (de) 1996-10-15
US5447951A (en) 1995-09-05
DE69304885T2 (de) 1997-03-27
EP0608671B1 (en) 1996-09-18
DE69304885D1 (de) 1996-10-24
IT1261165B (it) 1996-05-09
EP0608671A1 (en) 1994-08-03

Similar Documents

Publication Publication Date Title
HUP9800033A3 (en) Compositions for the treatment of dermatological disorders and methods for their use
FR2714594B3 (fr) Structure de diffuseur pour infusion de plantes médicinales.
FI953915A0 (fi) Dupuytrenin taudin lievittämiseen
IT8567279A1 (it) Apparecchio per l'applicazione controllata, sul tessuto umano, di sostanze riducenti per realizzare microabrasioni.
DE69534632D1 (de) Clorimazole metabolite in den behandlung vom sichelzellanämie
IT1290781B1 (it) Agente attivo terapeutico per il trattamento di malattie degenerative neuronali.
IT1178044B (it) Agente attivo farmaceutico per il trattamento di patologie cerebrali a base di uridina
ITRM930034A0 (it) Agente attivo per ridurre il livello ematico di glucocorticoidi e prevenire disturbi cerebrali da stress e senilita'.
IT1271567B (it) Procedimento per l'ulteriore trattamento di salcicce
EP0273310A3 (en) 5-aryl-3h-1,2,4-triazol-3-ones and their use as anticonvulsants
FR2685867B1 (fr) Compositions contre la desquamation de l'epiderme et du cuir chevelu.
FR2704392B1 (fr) Complément nutritionnel absorbable pour améliorer et optimiser les niveaux d'activité physique et cérébrale des individus.
NO960545D0 (no) Behandling av skadelige virkninger i forbindelse med administrering av ekstracellulært hemoglobin
ITRM940322A0 (it) "composizione farmaceutica contenente carbazolone per il trattamento di emicrania e disturbi psicotici e relativo metodo di preparazione edapplicazione".
IT1252659B (it) Procedimento per la depurazione dell'1,1,1-trifluoro-2-fluoroetano e dell'1,1,1-trifluoro-2,2-dicloroetano
IT1244562B (it) Agente per la prevenzione ed il trattamento dell'opacita' del cristallino.
IT9047551A0 (it) Impiego di a-amminofluorochetoni per la preparazione di medicamenti ad attivita' cardiovascolare e antipertensiva.
IT8721945A0 (it) Procedimento per la profumazione di libri, dispositivo per l'attuazione di detto procedimento
ITRM970235A0 (it) Catetere per la diagnosi e il trattamento dell'eiaculazione precoce
Shorter Spirit of Africa: The Healing Ministry of Archbishop Milingo of Zambia
Kieffer Cosmetic surgery of the aging face: social, psychological, and ethical implications
Grande Marlovian tragedy: the play of dilation
IT210395Z2 (it) Struttura di apparecchio per idromassaggi, in particolare perl'impiego in vasche da bagno.
ITBO940254A0 (it) Metodo per il miglioramento di alcune funzionalita' del corpo umano.
IT8609534A0 (it) Preparato,in particolare collirio o pomata,per il trattamento di alterazioni distrofiche e vascolari dei tessuti oculari.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970128